Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Prashanth T Bhaskar

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Developmental Cell|April 11, 2007
The two TORCs and AktPrashanth T Bhaskar, Nissim Hay
Cell Reports|July 21, 2015
Systemic Akt1 Deletion after Tumor Onset in p53(-/-) Mice Increases Lifespan and Regresses Thymic Lymphoma Emulating p53 RestorationWan-Ni Yu, Veronique Nogueira, Arya Sobhakumari, et al.
Molecular and Cellular Biology|July 22, 2009
mTORC1 hyperactivity inhibits serum deprivation-induced apoptosis via increased hexokinase II and GLUT1 expression, sustained Mcl-1 expression, and glycogen synthase kinase 3beta inhibitionPrashanth T Bhaskar, Veronique Nogueira, Krushna C Patra, et al.
Developmental Cell|April 24, 2010
FoxOs inhibit mTORC1 and activate Akt by inducing the expression of Sestrin3 and RictorChia-Chen Chen, Sang-Min Jeon, Prashanth T Bhaskar, et al.
Cancer Cell|October 19, 2006
Akt deficiency impairs normal cell proliferation and suppresses oncogenesis in a p53-independent and mTORC1-dependent mannerJennifer E Skeen, Prashanth T Bhaskar, Chia-Chen Chen, et al.
Cancer Cell|August 6, 2013
Hexokinase 2 is required for tumor initiation and maintenance and its systemic deletion is therapeutic in mouse models of cancerKrushna C Patra, Qi Wang, Prashanth T Bhaskar, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Developmental Cell|April 11, 2007
The two TORCs and AktPrashanth T Bhaskar, Nissim Hay
Cell Reports|July 21, 2015
Systemic Akt1 Deletion after Tumor Onset in p53(-/-) Mice Increases Lifespan and Regresses Thymic Lymphoma Emulating p53 RestorationWan-Ni Yu, Veronique Nogueira, Arya Sobhakumari, et al.
Molecular and Cellular Biology|July 22, 2009
mTORC1 hyperactivity inhibits serum deprivation-induced apoptosis via increased hexokinase II and GLUT1 expression, sustained Mcl-1 expression, and glycogen synthase kinase 3beta inhibitionPrashanth T Bhaskar, Veronique Nogueira, Krushna C Patra, et al.
Developmental Cell|April 24, 2010
FoxOs inhibit mTORC1 and activate Akt by inducing the expression of Sestrin3 and RictorChia-Chen Chen, Sang-Min Jeon, Prashanth T Bhaskar, et al.
Cancer Cell|October 19, 2006
Akt deficiency impairs normal cell proliferation and suppresses oncogenesis in a p53-independent and mTORC1-dependent mannerJennifer E Skeen, Prashanth T Bhaskar, Chia-Chen Chen, et al.
Cancer Cell|August 6, 2013
Hexokinase 2 is required for tumor initiation and maintenance and its systemic deletion is therapeutic in mouse models of cancerKrushna C Patra, Qi Wang, Prashanth T Bhaskar, et al.
Pageof 1